Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Development of Triheptanoin for Glucose Transporter Type I Deficiency

NCT02021526 is registered in ClinicalTrials.gov with Juan Pascual as lead sponsor.

NCT NCT02021526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02021526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Development of Triheptanoin for Glucose Transporter Type I Deficiency
Lead sponsor
Juan Pascual
Phase
Phase 1/2
Overall status
Withdrawn
Start date
December 31, 2015
Completion date
June 30, 2020
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glucose transporter type 1 deficiency syndrome, glut1 deficiency syndrome